SHR7390
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SHR7390, covering 2023-06-13 to 2023-06-13. Get the full timeline:
Most recent: Clinical Trial Update: SHR7390 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer [Phase 2]